Ligand Pharmaceuticals Incorporated Common Stock (NASDAQ: LGND) last traded at $286.29, down 0.38% on the session. The quote above updates while this page is open; the figures below are drawn from Ligand Pharmaceuticals Incorporated Common Stock’s own filings and are restated only when a new one is published.
Ligand Pharmaceuticals Incorporated Common Stock trades on NASDAQ under the ticker LGND. Its market capitalisation is $5.71 billion.
Valuation measures for Ligand Pharmaceuticals Incorporated Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $5.71B |
|---|---|
| Enterprise value | $5.92B |
| P/E ratio | 29.67 |
| Price / sales | 19.64 |
| Price / book | 5.90 |
| Beta | 0.80 |
Trailing-twelve-month figures tagged in Ligand Pharmaceuticals Incorporated Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $290.54M |
|---|---|
| Net income (TTM) | $197.22M |
| EPS (TTM) | $9.65 |
| Operating margin | 32.61% |
| Return on equity | 20.38% |
| Cash | $1.01B |
Range and volume for LGND over the past 52 weeks.
| 52-week high | $326.63 |
|---|---|
| 52-week low | $157.52 |
| Volume | 141.9K |
| Average volume | 360.5K |
| Previous close | $287.39 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.